GENEVA, June 24 -- BOEHRINGER INGELHEIM INTERNATIONAL GMBH filed a patent application (EP2025/084286) for “SPIROCYCLIC ANNULATED 2-AMINO-3-CYANO THIOPHENE DERIVATIVES AS KRAS INHIBITORS FOR THE TREATMENT OF CANCER”. With publication no. WO/2026/114916, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 498/10

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....